ATLANTA, Aug. 4, 2011 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq:ALIM) (“Alimera”), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced financial results for the second quarter ended June 30, 2011. Alimera will host a conference call at 4:30 p.m. ET today to discuss these results and provide a regulatory update.
